What does the Deutsche Bank action mean for the DSRLF analyst rating?

Deutsche Bank kept a **Hold** rating on **DSRLF** and raised its target to **EUR 74**. The rating stayed neutral, so the update signals slight upside but not a clear buy signal.

How significant is the new DSRLF price target of EUR 74?

The new target of **EUR 74** is **EUR 3** higher than the prior **EUR 71**, a **4.2%** increase. It is a modest revision and indicates minor valuation improvement.

How should investors use the DSRLF analyst rating in decisions?

Treat the DSRLF analyst rating as one data point. Combine it with company earnings, sector trends, and your risk profile before acting. A maintained Hold usually suggests no urgent position change.

Where can I find the source for this DSRLF analyst rating update?

The rating and price target change were reported by [The Fly](https://thefly.com/permalinks/entry.php/id4289531/4961286394/DSRLF-DiaSorin-price-target-raised-by-EUR--at-Deutsche-Bank) on February 10, 2026.

Analyst Ratings

Deutsche Bank Maintains Hold on DiaSorin S.p.A. (DSRLF) Feb 2026

ByHuzaifa Zahoor February 11, 2026February 11, 2026

Deutsche Bank maintained a Hold rating on DiaSorin S.p.A. (DSRLF) on February 10, 2026, while raising its price target to EUR 74 from EUR 71. This DSRLF analyst rating update signals a modest upward tweak to valuation, without a change in the broker’s view of the stock. The move shows Deutsche Bank sees incremental upside but still classifies the shares as neutral for now. Investors should note the target increase equals about 4.2% more than the prior target.